Charles River Laboratories International In (CRL)

74.01
NYSE : Health Care
Prev Close 74.01
Day Low/High 0.00 / 0.00
52 Wk Low/High 65.70 / 89.18
Avg Volume 476.40K
Exchange NYSE
Shares Outstanding 47.33M
Market Cap 3.41B
EPS 3.20
P/E Ratio 24.29
Div & Yield N.A. (N.A)

Latest News

Trader's Daily Notebook: For a Decline, It Sure Was Smooth

But we could see more volatility in the market.

Charles River Laboratories Announces Third-Quarter 2016 Results From Continuing Operations

Charles River Laboratories Announces Third-Quarter 2016 Results From Continuing Operations

Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the third quarter of 2016.

Charles River Announces Extension Of Integrated Discovery Program With Genentech

Charles River Announces Extension Of Integrated Discovery Program With Genentech

Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has extended its longstanding integrated drug discovery alliance with Genentech, a member of the Roche Group.

Charles River Laboratories Schedules Third-Quarter 2016 Earnings Release And Conference Call

Charles River Laboratories Schedules Third-Quarter 2016 Earnings Release And Conference Call

Charles River Laboratories International, Inc. (NYSE: CRL) will release third-quarter 2016 financial results on Wednesday, November 2 nd before the market opens.

Charles River Laboratories Acquires Agilux Laboratories, Inc.

Charles River Laboratories Acquires Agilux Laboratories, Inc.

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has acquired Agilux Laboratories, Inc.

Charles River Laboratories And The Tri-Insitutional Therapeutics Discovery Institute Announce Strategic Partnership

Charles River Laboratories And The Tri-Insitutional Therapeutics Discovery Institute Announce Strategic Partnership

Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has entered into a strategic partnership agreement with The Tri-Institutional Therapeutics Discovery Institute (Tri-I TDI), intended to...

Jim Cramer's Top Takeaways: Impinj, Charles River Labs

Jim Cramer's Top Takeaways: Impinj, Charles River Labs

Impinj is a speculative stock but would be good to own if there's a pullback.

Jim Cramer's 'Mad Money' Recap: Why You Shouldn't Be Jumping In and Out of Stocks

Jim Cramer's 'Mad Money' Recap: Why You Shouldn't Be Jumping In and Out of Stocks

This is not the time to sell in a panic, Cramer says.

Charles River Laboratories To Present At September Investor Conferences

Charles River Laboratories To Present At September Investor Conferences

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at three upcoming investor conferences, including: Baird 2016 Global Healthcare Conference in New York on...

Charles River Laboratories Announces Partnership With The Milner Therapeutics Institute And Consortium

Charles River Laboratories Announces Partnership With The Milner Therapeutics Institute And Consortium

Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has entered into a strategic partnership with the Milner Therapeutics Institute and Consortium.

Charles River Laboratories Announces Second-Quarter 2016 Results From Continuing Operations

Charles River Laboratories Announces Second-Quarter 2016 Results From Continuing Operations

Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the second quarter of 2016.

Today Charles River Laboratories International In (CRL) Hits New Lifetime High

Today Charles River Laboratories International In (CRL) Hits New Lifetime High

Trade-Ideas LLC identified Charles River Laboratories International In (CRL) as a new lifetime high candidate

Charles River Laboratories Schedules Second-Quarter 2016 Earnings Release And Conference Call

Charles River Laboratories Schedules Second-Quarter 2016 Earnings Release And Conference Call

Charles River Laboratories International, Inc. (NYSE: CRL) will release second-quarter 2016 financial results on Wednesday, August 3 rd before the market opens.

Healthcare Opportunities in Light of Brexit-Driven Selloff

Healthcare Opportunities in Light of Brexit-Driven Selloff

The sharp declines seen across the healthcare sector could present buying opportunities in companies such as Aetna, HCA, Icon and Paraxel.

Charles River Laboratories Acquires Blue Stream Laboratories

Charles River Laboratories Acquires Blue Stream Laboratories

Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has acquired Blue Stream Laboratories, Inc.

Charles River Labs (CRL) Stock Falls, Credit Suisse Initiates Coverage

Charles River Labs (CRL) Stock Falls, Credit Suisse Initiates Coverage

Shares of Charles River Labs (CRL) fell this afternoon as Credit Suisse initiated coverage of the company with a 'neutral' rating.

Charles River Laboratories To Present At Jefferies And William Blair Conferences

Charles River Laboratories To Present At Jefferies And William Blair Conferences

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the Jefferies 2016 Global Healthcare Conference in New York, New York on Wednesday, June 8 th, at 10:00 a.

Moderna Therapeutics And Charles River Laboratories Announce Strategic Collaboration To Scale Moderna's Nonclinical Development Efforts For Novel MRNA Therapeutics

Moderna Therapeutics And Charles River Laboratories Announce Strategic Collaboration To Scale Moderna's Nonclinical Development Efforts For Novel MRNA Therapeutics

Moderna Therapeutics, a clinical stage pioneer in the development of messenger RNA (mRNA) Therapeutics™ and Charles River Laboratories International, Inc.

New Lifetime High Reached By Charles River Laboratories International In (CRL)

New Lifetime High Reached By Charles River Laboratories International In (CRL)

Trade-Ideas LLC identified Charles River Laboratories International In (CRL) as a new lifetime high candidate

Charles River Laboratories International In (CRL) Reaches New Lifetime High Today

Charles River Laboratories International In (CRL) Reaches New Lifetime High Today

Trade-Ideas LLC identified Charles River Laboratories International In (CRL) as a new lifetime high candidate

Charles River Laboratories International In (CRL) Reaches New Lifetime High Today

Charles River Laboratories International In (CRL) Reaches New Lifetime High Today

Trade-Ideas LLC identified Charles River Laboratories International In (CRL) as a new lifetime high candidate

Charles River Laboratories Announces First-Quarter 2016 Results From Continuing Operations

Charles River Laboratories Announces First-Quarter 2016 Results From Continuing Operations

Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the first quarter of 2016.

Charles River Laboratories And BioMotiv Enter Into Strategic Partnership

Charles River Laboratories And BioMotiv Enter Into Strategic Partnership

Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has entered into a strategic partnership with BioMotiv, LLC, the therapeutic accelerator company associated with The Harrington Project for...

Charles River Laboratories Schedules First-Quarter 2016 Earnings Release And Conference Call

Charles River Laboratories Schedules First-Quarter 2016 Earnings Release And Conference Call

Charles River Laboratories International, Inc. (NYSE: CRL) will release first-quarter 2016 financial results on Wednesday, May 4 th before the market opens.

Charles River Laboratories Completes The Acquisition Of WIL Research

Charles River Laboratories Completes The Acquisition Of WIL Research

Charles River Laboratories International, Inc. (NYSE:CRL) announced today that it has completed the previously announced acquisition of WIL Research for approximately $585 million in cash, subject to certain customary...

Barbarian At The Gate: Charles River Laboratories International In (CRL)

Barbarian At The Gate: Charles River Laboratories International In (CRL)

Trade-Ideas LLC identified Charles River Laboratories International In (CRL) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate

Short Interest Jumps 13% For CRL

Short Interest Jumps 13% For CRL

The most recent short interest data has been released by the NASDAQ for the 03/01/2016 settlement date, which shows a 272,521 share increase in total short interest for Charles River Laboratories International Inc. , to 2,346,986, an increase of 13.14% since 02/12/2016.

Charles River Laboratories To Present At Raymond James Conference

Charles River Laboratories To Present At Raymond James Conference

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the Raymond James 37 th Annual Institutional Investors Conference in Orlando, Florida on Tuesday, March 8 th, at 10:25 a.